In accordance with these theoretical considerations, IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), and TNF-α were reduced in people being treated with 20 mg of apremilast twice daily for psoriasis or psoriatic arthritis [8,9]. The gene discussed is CCL2; the disease is psoriasis.